FDA Adverse Event Death Summary report: N

NURSE ASSIST, LLC

MDR report key: 20788373 · Received November 26, 2024

Report

Report Number
3002695476-2024-00051
Event Type
Death
Date Received
November 26, 2024
Date of Event
November 12, 2023
Report Date
November 22, 2024
Manufacturer
NURSE ASSIST, LLC
Product Code
FRO
PMA / PMN Number
K083042
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BASED ON AN EVENT FROM (B)(6) 2023. THE DEVICE HAS NOT BEEN RETURNED FOR ANALYSIS. AN ANALYSIS OF THE DEVICE LOT RECORDS INDICATES THAT THE PRODUCT MET ALL SPECIFICATIONS AND RELEASE REQUIREMENTS. BASED ON THE AVAILABLE INFORMATION IN THE COMPLAINT FILE AND INVESTIGATION CONDUCTED BY NURSE ASSIST AND OUR MEDICAL DIRECTOR, THERE IS NO CLEAR EVIDENCE TO REASONABLY SUGGEST THAT STERICARE 0.9% SODIUM CHLORIDE SALINE SOLUTION MAY HAVE BEEN A CAUSE OF THE REPORTED EVENT AND RESULTING HARM (SEPSIS). OTHER MOST LIKELY FACTORS THAT MAY HAVE CONTRIBUTED TO THE EVENT INCLUDE (MAY NOT BE LIMITED TO) PATIENT SPECIFIC CONDITIONS (EG: LYMPHODEMA OR GRAFT-VERSUS-HOST-DISEASE OR THE UNDERLYING CONDITION OF LYMPHOMA AND THE RESULTANT TREATMENT WITH HIGH DOSE CHEMOTHERAPY AND BONE MARROW TRANSPLANT WOULD HAVE LEFT THE PATIENT IN A PERSISTENT IMMUNE-COMPROMISED STATE).

Additional Manufacturer Narrative · 0

THIS REPORT IS BASED ON AN EVENT FROM (B)(6) 2023. THE DEVICE HAS NOT BEEN RETURNED FOR ANALYSIS. AN ANALYSIS OF THE DEVICE LOT RECORDS INDICATES THAT THE PRODUCT MET ALL SPECIFICATIONS AND RELEASE REQUIREMENTS. BASED ON THE AVAILABLE INFORMATION IN THE COMPLAINT FILE AND INVESTIGATION CONDUCTED BY NURSE ASSIST AND OUR MEDICAL DIRECTOR, THERE IS NO CLEAR EVIDENCE TO REASONABLY SUGGEST THAT STERICARE 0.9% SODIUM CHLORIDE SALINE SOLUTION MAY HAVE BEEN A CAUSE OF THE REPORTED EVENT AND RESULTING HARM (SEPSIS). OTHER MOST LIKELY FACTORS THAT MAY HAVE CONTRIBUTED TO THE EVENT INCLUDE (MAY NOT BE LIMITED TO) PATIENT SPECIFIC CONDITIONS (EG: LYMPHODEMA OR GRAFT-VERSUS-HOST-DISEASE OR THE UNDERLYING CONDITION OF LYMPHOMA AND THE RESULTANT TREATMENT WITH HIGH DOSE CHEMOTHERAPY AND BONE MARROW TRANSPLANT WOULD HAVE LEFT THE PATIENT IN A PERSISTENT IMMUNE-COMPROMISED STATE).

Description of Event or Problem · 0

THE DECEDENT WAS DIAGNOSED WITH LYMPHOMA ON OR AROUND 2016 AND RECEIVED A BONE MARROW TRANSPLANT IN 2016. THE DECEDENT DEVELOPED LYMPHEDEMA IN 2021. ON OR AROUND (B)(6) 2023, HE DEVELOPED GRAFT-VERSUS-HOST DISEASE, AND THE LYMPHEDEMA WORSENED. THE REPORT INDICATED THE DECEDENT USED 1 BOTTLE OF SOLUTION ON HIS OPEN WOUNDS AND CUTS FOR A FEW WEEKS. THE DECEDENT SUFFERED FROM LYMPHEDEMA, A CONDITION WHICH CAUSED HIM TO EXPERIENCE WOUNDS AND INFECTIONS AROUND HIS LEGS. THE DECEDENT WAS PRESCRIBED 4 BOTTLES OF 0.9% SODIUM CHLORIDE SALINE SOLUTION ON OR AROUND (B)(6) 2023 BY CITY OF HOPE HOSPITAL IN DUARTE, CALIFORNIA TO CLEAN HIS WOUNDS AND INFECTIONS. THE DECEDENT WAS SUPPLIED 4 BOTTLES OF NURSE ASSIST, LLC 0.9% SODIUM CHLORIDE SALINE SOLUTION BY BRYAM HEALTHCARE CENTERS, INC ON OR AROUND (B)(6) 2023. AFTER USING 1 OF THE 4 BOTTLES, THE DECEDENT BEGAN SUFFERING FROM EXTREME PAIN, ABNORMAL SWELLING, A CHANGE IN SKIN COLOR AND PAIN ON HIS WOUNDS AND INFECTIONS. THE DECEDENT WAS TRANSPORTED TO A LOCAL HOSPITAL ON OR AROUND (B)(6) 2023, AFTER ARRIVING HE WENT INTO SEPTIC SHOCK AND CARDIAC ARREST AND PASSED AWAY.

Description of Event or Problem · 0

THE DECEDENT WAS DIAGNOSED WITH LYMPHOMA ON OR AROUND 2016 AND RECEIVED A BONE MARROW TRANSPLANT IN 2016. THE DECEDENT DEVELOPED LYMPHEDEMA IN 2021. ON OR AROUND (B)(6) 2023, HE DEVELOPED GRAFT-VERSUS-HOST DISEASE, AND THE LYMPHEDEMA WORSENED. THE REPORT INDICATED THE DECEDENT USED 1 BOTTLE OF SOLUTION ON HIS OPEN WOUNDS AND CUTS FOR A FEW WEEKS. THE DECEDENT SUFFERED FROM LYMPHEDEMA, A CONDITION WHICH CAUSED HIM TO EXPERIENCE WOUNDS AND INFECTIONS AROUND HIS LEGS. THE DECEDENT WAS PRESCRIBED 4 BOTTLES OF 0.9% SODIUM CHLORIDE SALINE SOLUTION ON OR AROUND (B)(6) 2023 BY (B)(6) HOSPITAL IN (B)(6), CALIFORNIA TO CLEAN HIS WOUNDS AND INFECTIONS. THE DECEDENT WAS SUPPLIED 4 BOTTLES OF NURSE ASSIST, LLC 0.9% SODIUM CHLORIDE SALINE SOLUTION BY (B)(6) CENTERS, INC ON OR AROUND (B)(6) 2023. AFTER USING 1 OF THE 4 BOTTLES, THE DECEDENT BEGAN SUFFERING FROM EXTREME PAIN, ABNORMAL SWELLING, A CHANGE IN SKIN COLOR AND PAIN ON HIS WOUNDS AND INFECTIONS. THE DECEDENT WAS TRANSPORTED TO A LOCAL HOSPITAL ON OR AROUND (B)(6) 2023, AFTER ARRIVING HE WENT INTO SEPTIC SHOCK AND CARDIAC ARREST AND PASSED AWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2360218 NURSE ASSIST, LLC 0.9% NORMAL SALINE FOR IRRIGATION USP IN SCREW BOTTLE TOP FRO NURSE ASSIST, LLC 6270 23076070

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Hospitalization| D